Annual Report 2023-2024 available

Advancing Tick-Borne Disease Research: Insights & Progress Event 30 April

Senior couple walking on the beach

Support Osteoarthritis Research

The Osteoarthritis Clinical Research Group, led by Professor David Hunter, is a globally recognised group of researchers and clinicians dedicated to advancing osteoarthritis treatment. Through cutting-edge clinical and translational research, they are revolutionising care to improve patient outcomes and quality of life.
Osteoarthritis research
Kolling Institute
5 Projects
View Facility
13%
$150,000
$18,849
$131,151

Overview

Osteoarthritis, once thought to be an unavoidable part of ageing, is now recognised as a condition that can be managed and treated. However, despite advances in care, there is still no cure, and the number of people affected is expected to rise significantly in the coming years.

As the most common chronic joint disease in Australia, osteoarthritis affects 1 in 8 people, leading to pain, disability, and early retirement. It can develop at any age, with risk factors including joint injuries, obesity, and genetic predisposition. Without improved treatments and prevention strategies, the growing burden of osteoarthritis will place increasing strain on individuals, families, and the healthcare system.

The Osteoarthritis Clinical Research Group is dedicated to advancing osteoarthritis research – exploring innovative treatments, improving early diagnosis, and ultimately working towards a cure. Through groundbreaking clinical trials, researchers are developing and testing new therapies to slow disease progression, improve pain management, and restore joint function. By investing in research today, there is hope for a future where osteoarthritis no longer limits lives.


About Osteoarthritis

The most common joint disease

Osteoarthritis is the most common chronic joint disease in Australia, affecting 1 in 8 people.

A leading cause of disability

The disease can develop at any age and is a major cause of pain, disability, and early retirement.

No cure, and cases are rising

Currently, there is no cure for osteoarthritis, and the number of people with the disease is expected to increase significantly.

Higher prevalence in women

Women are more likely to develop osteoarthritis, accounting for 63% of cases in Australia.

Increased risk of other health conditions

People with osteoarthritis have a greater likelihood of developing heart disease, diabetes, and depression.

Linked to previous joint injuries

Osteoarthritis is more common in people who have had past joint injuries, including sports injuries and fractures.
Older woman suffering from osteoarthritis
YOUR SUPPORT MATTERS

Why Support Osteoarthritis Research?

Osteoarthritis is a progressive and debilitating disease with no cure, affecting millions of people worldwide. Despite its widespread impact, research funding remains limited.

The Osteoarthritis Clinical Research Group is dedicated to finding better ways to diagnose, treat, and prevent the disease, but they rely on funding to continue their vital work.

Supporting this research helps drive critical advancements that can improve lives, reduce the burden on healthcare systems, and pave the way for a future where osteoarthritis is no longer a life-limiting condition.

Donate to Osteoarthritis Research

Meet the Osteoarthritis Research team

David Hunter
Professor David Hunter
View bio
Dr Jillian Eyles
Dr Jillian Eyles
View bio
Dr Jocelyn Bowden
Dr Jocelyn Bowden
View bio
Dr Karen Bracken
Dr Karen Bracken
View bio
Dr Michelle Hall
Dr Michelle Hall
View bio
Dr Sarah Kobayashi
Dr Sarah Kobayashi
View bio
Dr Vicky Duong
Dr Vicky Duong
View bio

You can shape the future
of healthcare for all

Give a gift that makes a real difference to our healthcare staff and facilities so they can deliver the best patient care.
Skip to content